Yimei Yue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yimei Yue has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Pham Pacia
From the Department of Biomedical Engineering, Washington University in St Louis, 4511 Forest Park Ave, St Louis, MO 63108 (C.P.P., J.Y., Y.Y., E.C.L., H.C.); Department of Neurosurgery (E.C.L.), Mallinckrodt Institute of Radiology (T.L.S.B., A.N.), and Department of Radiation Oncology (H.C.), Washington University School of Medicine, St Louis, Mo
3 shared publications - Hong Chen
Department of Biomedical Engineering, Washington University in St. Louis, Saint Louis, MO, 63130, USA
3 shared publications - Chih-Yen Chien
Department of Biomedical Engineering, Washington University in St. Louis, USA
2 shared publications - Dezhuang Ye
Department of Biomedical Engineering, Washington University in St. Louis, Saint Louis, USA
2 shared publications - Yaoheng Yang
Department of Biomedical Engineering, Washington University in St. Louis, Saint Louis, USA
2 shared publications - Arash Nazeri
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States
1 shared publication
Latest Publications
- 1 April 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (2) , e220869
Focused Ultrasound–mediated Liquid Biopsy in a Tauopathy Mouse Model
Background Neurodegenerative disorders (such as Alzheimer disease) characterized by the deposition of various pathogenic forms of tau protein in the brain are collectively referred to as tauopathies. Identification of the molecular drivers and pathways of neurodegeneration is critical to individualized targeted treatment of these disorders. However, despite important advances in fluid biomarker detection, characterization of these molecular subtypes is limited by the blood-brain barrier. Purpose To evaluate the feasibility and safety of focused ultrasound-mediated liquid biopsy (sonobiopsy) in the detection of brain-derived protein biomarkers in a transgenic mouse model of tauopathy (PS19 mice). Materials and Methods Sonobiopsy was performed by sonicating the cerebral hemisphere in 2-month-old PS19 and wild-type mice, followed by measurement of plasma phosphorylated tau (p-tau) species (30 minutes after sonication in the sonobiopsy group). Next, spatially targeted sonobiopsy was performed by sonicating either the cerebral cortex or the hippocampus in 6-month-old PS19 mice. To detect changes in plasma neurofilament light chain (a biomarker of neurodegeneration) levels, blood samples were collected before and after sonication (15 and 45-60 minutes after sonication). Histologic staining was performed to evaluate tissue damage after sonobiopsy. The Shapiro-Wilk test, unpaired and paired t tests, and the Mann-Whitney U test were used. Results In the 2-month-old mice, sonobiopsy significantly increased the normalized levels of plasma p-tau species compared with the conventional blood-based liquid biopsy (p-tau-181-to-mouse tau [m-tau] ratio: 1.7-fold increase, P = .006; p-tau-231-to-m-tau ratio: 1.4-fold increase, P = .048). In the 6-month-old PS19 mice, spatially targeted sonobiopsy resulted in a 2.3-fold increase in plasma neurofilament light chain after sonication of the hippocampus and cerebral cortex (P < .001). After optimization of the sonobiopsy parameters, no excess microhemorrhage was observed in the treated cerebral hemisphere compared with the contralateral side. Conclusion This study showed the feasibility of sonobiopsy to release phosphorylated tau species and neurofilament light chain to the blood circulation, potentially facilitating diagnosis of neurodegenerative disorders. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Fowlkes in this issue.
- 1 April 2023
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (2) , e220869
Focused Ultrasound–mediated Liquid Biopsy in a Tauopathy Mouse Model
Background Neurodegenerative disorders (such as Alzheimer disease) characterized by the deposition of various pathogenic forms of tau protein in the brain are collectively referred to as tauopathies. Identification of the molecular drivers and pathways of neurodegeneration is critical to individualized targeted treatment of these disorders. However, despite important advances in fluid biomarker detection, characterization of these molecular subtypes is limited by the blood-brain barrier. Purpose To evaluate the feasibility and safety of focused ultrasound-mediated liquid biopsy (sonobiopsy) in the detection of brain-derived protein biomarkers in a transgenic mouse model of tauopathy (PS19 mice). Materials and Methods Sonobiopsy was performed by sonicating the cerebral hemisphere in 2-month-old PS19 and wild-type mice, followed by measurement of plasma phosphorylated tau (p-tau) species (30 minutes after sonication in the sonobiopsy group). Next, spatially targeted sonobiopsy was performed by sonicating either the cerebral cortex or the hippocampus in 6-month-old PS19 mice. To detect changes in plasma neurofilament light chain (a biomarker of neurodegeneration) levels, blood samples were collected before and after sonication (15 and 45-60 minutes after sonication). Histologic staining was performed to evaluate tissue damage after sonobiopsy. The Shapiro-Wilk test, unpaired and paired t tests, and the Mann-Whitney U test were used. Results In the 2-month-old mice, sonobiopsy significantly increased the normalized levels of plasma p-tau species compared with the conventional blood-based liquid biopsy (p-tau-181-to-mouse tau [m-tau] ratio: 1.7-fold increase, P = .006; p-tau-231-to-m-tau ratio: 1.4-fold increase, P = .048). In the 6-month-old PS19 mice, spatially targeted sonobiopsy resulted in a 2.3-fold increase in plasma neurofilament light chain after sonication of the hippocampus and cerebral cortex (P < .001). After optimization of the sonobiopsy parameters, no excess microhemorrhage was observed in the treated cerebral hemisphere compared with the contralateral side. Conclusion This study showed the feasibility of sonobiopsy to release phosphorylated tau species and neurofilament light chain to the blood circulation, potentially facilitating diagnosis of neurodegenerative disorders. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Fowlkes in this issue.
- 1 October 2021
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 150 (4_Suppleme) , A29-A30
Static magnetic fields dampen focused ultrasound-induced cavitation and blood-brain barrier opening outcome
MRI-guided focused ultrasound combined with microbubbles has been used in clinical studies for blood-brain barrier (BBB) opening. However, the impact of the static magnetic field generated by an MRI scanner on the BBB opening outcome has not been evaluated. The objective of this study was to determine the relationship of the static magnetic field of an MRI scanner on focused ultrasound combined with microbubble-induced BBB opening. Mice were divided into four groups which were sonicated by FUS in different static magnetic fields B0 (∼0T, 1.5T, 3.0T, and 4.7T) with all other experimental parameters kept the same. Microbubble cavitation activity was monitored by passive cavitation detection during FUS after microbubble injection. After sonication, contrast-enhanced T1-weighted MRI and Evans blue were used to evaluate the BBBO outcome. The microbubble cavitation dose decreased by an average of 2.1 dB at 1.5T (P = 0.05), 2.9 dB at 3.0T (Pi = 0.01), and 3.0 dB at 4.7T (P = 0.01) compared with that outside the magnetic field. It also decreased Evans blue trans-BBB delivery 1.4-fold at1.5T (P = 0.009), 1.6-fold at 3.0T (P < 0.001), and 1.9-fold at 4.7T (P < 0.001). These findings demonstrated that static magnetic fields dampened microbubble cavitation and decreased trans-BBB delivery by FUS.
- 1 October 2021
- Published by Acoustical Society of America (ASA) in The Journal of the Acoustical Society of America
- Vol. 150 (4_Suppleme) , A29-A30
Static magnetic fields dampen focused ultrasound-induced cavitation and blood-brain barrier opening outcome
MRI-guided focused ultrasound combined with microbubbles has been used in clinical studies for blood-brain barrier (BBB) opening. However, the impact of the static magnetic field generated by an MRI scanner on the BBB opening outcome has not been evaluated. The objective of this study was to determine the relationship of the static magnetic field of an MRI scanner on focused ultrasound combined with microbubble-induced BBB opening. Mice were divided into four groups which were sonicated by FUS in different static magnetic fields B0 (∼0T, 1.5T, 3.0T, and 4.7T) with all other experimental parameters kept the same. Microbubble cavitation activity was monitored by passive cavitation detection during FUS after microbubble injection. After sonication, contrast-enhanced T1-weighted MRI and Evans blue were used to evaluate the BBBO outcome. The microbubble cavitation dose decreased by an average of 2.1 dB at 1.5T (P = 0.05), 2.9 dB at 3.0T (Pi = 0.01), and 3.0 dB at 4.7T (P = 0.01) compared with that outside the magnetic field. It also decreased Evans blue trans-BBB delivery 1.4-fold at1.5T (P = 0.009), 1.6-fold at 3.0T (P < 0.001), and 1.9-fold at 4.7T (P < 0.001). These findings demonstrated that static magnetic fields dampened microbubble cavitation and decreased trans-BBB delivery by FUS.
- 6 July 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 300 (3) , 681-689
Static Magnetic Fields Dampen Focused Ultrasound–mediated Blood-Brain Barrier Opening
The static magnetic field of an MRI scanner was found to dampen microbubble cavitation activity and decrease the focused ultrasound combined with microbubble-mediated blood-brain barrier opening. Background Focused ultrasound combined with microbubbles has been used in clinical studies for blood-brain barrier (BBB) opening in conjunction with MRI. However, the impact of the static magnetic ...
- 6 July 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 300 (3) , 681-689
Static Magnetic Fields Dampen Focused Ultrasound–mediated Blood-Brain Barrier Opening
The static magnetic field of an MRI scanner was found to dampen microbubble cavitation activity and decrease the focused ultrasound combined with microbubble-mediated blood-brain barrier opening. Background Focused ultrasound combined with microbubbles has been used in clinical studies for blood-brain barrier (BBB) opening in conjunction with MRI. However, the impact of the static magnetic ...